APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short-Acting Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Short-Acting Anesthetic Market Outlook and Growth Opportunities 2026

30 December 2025203 pages

Choose your research edition.

Industry ResearchShort-Acting Anesthetic Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-Acting Anesthetic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Short-Acting Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-Acting Anesthetic Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-Acting Anesthetic Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Short-Acting Anesthetic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Short-Acting Anesthetic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Short-Acting Anesthetic market include Aspen Pharmacare, Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius-Kabi, Hikma Pharmaceuticals, Hospira, Paion, Piramal Critical Care and Septodont, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Short-Acting Anesthetic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Short-Acting Anesthetic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Short-Acting Anesthetic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Short-Acting Anesthetic market size, projected growth trends, production technologies, key applications, and end-use industries.

Short-Acting Anesthetic Segment by Company

Aspen Pharmacare

Baxter Healthcare

Dr. Reddy's Laboratories

Fresenius-Kabi

Hikma Pharmaceuticals

Hospira

Paion

Piramal Critical Care

Septodont

AstraZeneca

AbbVie

B. Braun

Cisen Pharmaceutical

Pfizer

Yingke Biopharmaceutical

SSY Group

Baili-Pharm

Eisai

Short-Acting Anesthetic Segment by Type

Local

General

Short-Acting Anesthetic Segment by Application

Hospital

Clinic

Short-Acting Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Short-Acting Anesthetic status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Short-Acting Anesthetic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Short-Acting Anesthetic significant trends, drivers, influence factors in global and regions.

6. To analyze Short-Acting Anesthetic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-Acting Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-Acting Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-Acting Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Short-Acting Anesthetic market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Short-Acting Anesthetic industry.

Chapter 3: Detailed analysis of Short-Acting Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Short-Acting Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Short-Acting Anesthetic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Short-Acting Anesthetic Industry Trends Table 2. Short-Acting Anesthetic Industry Drivers Table 3. Short-Acting Anesthetic Industry Opportunities and Challenges Table 4. Short-Acting Anesthetic Industry Restraints Table 5. Global Short-Acting Anesthetic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Short-Acting Anesthetic Revenue Share by Company (2021-2026) Table 7. Global Short-Acting Anesthetic Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Short-Acting Anesthetic Sales Volume Share by Company (2021-2026) Table 9. Global Short-Acting Anesthetic Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Short-Acting Anesthetic Company Ranking, (2024-2026) & (USD Million) Table 11. Global Short-Acting Anesthetic Key Company Manufacturing Base & Headquarters Table 12. Global Short-Acting Anesthetic Company, Product Type & Application Table 13. Global Short-Acting Anesthetic Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Short-Acting Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Local Table 18. Significant Companies of General Table 19. Global Short-Acting Anesthetic Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Short-Acting Anesthetic Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Short-Acting Anesthetic Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Short-Acting Anesthetic Sales Volume Share by Type (2021-2026) Table 23. Global Short-Acting Anesthetic Sales Volume Share by Type (2027-2032) Table 24. Global Short-Acting Anesthetic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Short-Acting Anesthetic Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Short-Acting Anesthetic Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Short-Acting Anesthetic Sales Value Share by Type (2021-2026) Table 28. Global Short-Acting Anesthetic Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Short-Acting Anesthetic Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Short-Acting Anesthetic Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Short-Acting Anesthetic Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Short-Acting Anesthetic Sales Volume Share by Application (2021-2026) Table 35. Global Short-Acting Anesthetic Sales Volume Share by Application (2027-2032) Table 36. Global Short-Acting Anesthetic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Short-Acting Anesthetic Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Short-Acting Anesthetic Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Short-Acting Anesthetic Sales Value Share by Application (2021-2026) Table 40. Global Short-Acting Anesthetic Sales Value Share by Application (2027-2032) Table 41. Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Short-Acting Anesthetic Sales by Region (2021-2026) & (K Units) Table 43. Global Short-Acting Anesthetic Sales Market Share by Region (2021-2026) Table 44. Global Short-Acting Anesthetic Sales by Region (2027-2032) & (K Units) Table 45. Global Short-Acting Anesthetic Sales Market Share by Region (2027-2032) Table 46. Global Short-Acting Anesthetic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Short-Acting Anesthetic Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Short-Acting Anesthetic Sales Value Share by Region (2021-2026) Table 49. Global Short-Acting Anesthetic Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Short-Acting Anesthetic Sales Value Share by Region (2027-2032) Table 51. Global Short-Acting Anesthetic Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Short-Acting Anesthetic Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Short-Acting Anesthetic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Short-Acting Anesthetic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 56. Global Short-Acting Anesthetic Sales Market Share by Country (2021-2026) Table 57. Global Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 58. Global Short-Acting Anesthetic Sales Market Share by Country (2027-2032) Table 59. Global Short-Acting Anesthetic Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Short-Acting Anesthetic Sales Value Market Share by Country (2021-2026) Table 61. Global Short-Acting Anesthetic Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Short-Acting Anesthetic Sales Value Market Share by Country (2027-2032) Table 63. Aspen Pharmacare Company Information Table 64. Aspen Pharmacare Business Overview Table 65. Aspen Pharmacare Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Aspen Pharmacare Short-Acting Anesthetic Product Portfolio Table 67. Aspen Pharmacare Recent Development Table 68. Baxter Healthcare Company Information Table 69. Baxter Healthcare Business Overview Table 70. Baxter Healthcare Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Baxter Healthcare Short-Acting Anesthetic Product Portfolio Table 72. Baxter Healthcare Recent Development Table 73. Dr. Reddy's Laboratories Company Information Table 74. Dr. Reddy's Laboratories Business Overview Table 75. Dr. Reddy's Laboratories Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio Table 77. Dr. Reddy's Laboratories Recent Development Table 78. Fresenius-Kabi Company Information Table 79. Fresenius-Kabi Business Overview Table 80. Fresenius-Kabi Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Fresenius-Kabi Short-Acting Anesthetic Product Portfolio Table 82. Fresenius-Kabi Recent Development Table 83. Hikma Pharmaceuticals Company Information Table 84. Hikma Pharmaceuticals Business Overview Table 85. Hikma Pharmaceuticals Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio Table 87. Hikma Pharmaceuticals Recent Development Table 88. Hospira Company Information Table 89. Hospira Business Overview Table 90. Hospira Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hospira Short-Acting Anesthetic Product Portfolio Table 92. Hospira Recent Development Table 93. Paion Company Information Table 94. Paion Business Overview Table 95. Paion Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Paion Short-Acting Anesthetic Product Portfolio Table 97. Paion Recent Development Table 98. Piramal Critical Care Company Information Table 99. Piramal Critical Care Business Overview Table 100. Piramal Critical Care Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Piramal Critical Care Short-Acting Anesthetic Product Portfolio Table 102. Piramal Critical Care Recent Development Table 103. Septodont Company Information Table 104. Septodont Business Overview Table 105. Septodont Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Septodont Short-Acting Anesthetic Product Portfolio Table 107. Septodont Recent Development Table 108. AstraZeneca Company Information Table 109. AstraZeneca Business Overview Table 110. AstraZeneca Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. AstraZeneca Short-Acting Anesthetic Product Portfolio Table 112. AstraZeneca Recent Development Table 113. AbbVie Company Information Table 114. AbbVie Business Overview Table 115. AbbVie Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. AbbVie Short-Acting Anesthetic Product Portfolio Table 117. AbbVie Recent Development Table 118. B. Braun Company Information Table 119. B. Braun Business Overview Table 120. B. Braun Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. B. Braun Short-Acting Anesthetic Product Portfolio Table 122. B. Braun Recent Development Table 123. Cisen Pharmaceutical Company Information Table 124. Cisen Pharmaceutical Business Overview Table 125. Cisen Pharmaceutical Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio Table 127. Cisen Pharmaceutical Recent Development Table 128. Pfizer Company Information Table 129. Pfizer Business Overview Table 130. Pfizer Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Pfizer Short-Acting Anesthetic Product Portfolio Table 132. Pfizer Recent Development Table 133. Yingke Biopharmaceutical Company Information Table 134. Yingke Biopharmaceutical Business Overview Table 135. Yingke Biopharmaceutical Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio Table 137. Yingke Biopharmaceutical Recent Development Table 138. SSY Group Company Information Table 139. SSY Group Business Overview Table 140. SSY Group Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. SSY Group Short-Acting Anesthetic Product Portfolio Table 142. SSY Group Recent Development Table 143. Baili-Pharm Company Information Table 144. Baili-Pharm Business Overview Table 145. Baili-Pharm Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Baili-Pharm Short-Acting Anesthetic Product Portfolio Table 147. Baili-Pharm Recent Development Table 148. Eisai Company Information Table 149. Eisai Business Overview Table 150. Eisai Short-Acting Anesthetic Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Eisai Short-Acting Anesthetic Product Portfolio Table 152. Eisai Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Short-Acting Anesthetic Distributors List Table 156. Short-Acting Anesthetic Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Short-Acting Anesthetic Product Image Figure 2. Global Short-Acting Anesthetic Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 4. Global Short-Acting Anesthetic Sales (2021-2032) & (K Units) Figure 5. Global Short-Acting Anesthetic Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Short-Acting Anesthetic Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Local Image Figure 10. General Image Figure 11. Global Short-Acting Anesthetic Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Short-Acting Anesthetic Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Short-Acting Anesthetic Sales Volume Share by Type (2021-2032) Figure 14. Global Short-Acting Anesthetic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Short-Acting Anesthetic Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Short-Acting Anesthetic Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Short-Acting Anesthetic Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Short-Acting Anesthetic Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Short-Acting Anesthetic Sales Volume Share by Application (2021-2032) Figure 22. Global Short-Acting Anesthetic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Short-Acting Anesthetic Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Short-Acting Anesthetic Sales Value Share by Application (2021-2032) Figure 25. Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Short-Acting Anesthetic Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Short-Acting Anesthetic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Short-Acting Anesthetic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 30. North America Short-Acting Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Short-Acting Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Short-Acting Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 36. South America Short-Acting Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Short-Acting Anesthetic Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Short-Acting Anesthetic Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Short-Acting Anesthetic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Short-Acting Anesthetic Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Short-Acting Anesthetic Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Local
  • General
Applications
  • Hospital
  • Clinic
Companies covered
  • Aspen Pharmacare
  • Baxter Healthcare
  • Dr. Reddy's Laboratories
  • Fresenius-Kabi
  • Hikma Pharmaceuticals
  • Hospira
  • Paion
  • Piramal Critical Care
  • Septodont
  • AstraZeneca
  • AbbVie
  • B. Braun
  • Cisen Pharmaceutical
  • Pfizer
  • Yingke Biopharmaceutical
  • SSY Group
  • Baili-Pharm
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Short-Acting Anesthetic Sales Value (2021-2032)
  4. 1.2.2 Global Short-Acting Anesthetic Sales Volume (2021-2032)
  5. 1.2.3 Global Short-Acting Anesthetic Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Short-Acting Anesthetic Market Dynamics
  1. 2.1 Short-Acting Anesthetic Industry Trends
  2. 2.2 Short-Acting Anesthetic Industry Drivers
  3. 2.3 Short-Acting Anesthetic Industry Opportunities and Challenges
  4. 2.4 Short-Acting Anesthetic Industry Restraints
3 Short-Acting Anesthetic Market by Company
  1. 3.1 Global Short-Acting Anesthetic Company Revenue Ranking in 2025
  2. 3.2 Global Short-Acting Anesthetic Revenue by Company (2021-2026)
  3. 3.3 Global Short-Acting Anesthetic Sales Volume by Company (2021-2026)
  4. 3.4 Global Short-Acting Anesthetic Average Price by Company (2021-2026)
  5. 3.5 Global Short-Acting Anesthetic Company Ranking (2024-2026)
  6. 3.6 Global Short-Acting Anesthetic Company Manufacturing Base and Headquarters
  7. 3.7 Global Short-Acting Anesthetic Company Product Type and Application
  8. 3.8 Global Short-Acting Anesthetic Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Short-Acting Anesthetic Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Short-Acting Anesthetic Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Short-Acting Anesthetic Market by Type
  1. 4.1 Short-Acting Anesthetic Type Introduction
  2. 4.1.1 Local
  3. 4.1.2 General
  4. 4.2 Global Short-Acting Anesthetic Sales Volume by Type
  5. 4.2.1 Global Short-Acting Anesthetic Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Short-Acting Anesthetic Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Short-Acting Anesthetic Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Short-Acting Anesthetic Sales Value by Type
  9. 4.3.1 Global Short-Acting Anesthetic Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Short-Acting Anesthetic Sales Value by Type (2021-2032)
  11. 4.3.3 Global Short-Acting Anesthetic Sales Value Share by Type (2021-2032)
5 Short-Acting Anesthetic Market by Application
  1. 5.1 Short-Acting Anesthetic Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Short-Acting Anesthetic Sales Volume by Application
  5. 5.2.1 Global Short-Acting Anesthetic Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Short-Acting Anesthetic Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Short-Acting Anesthetic Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Short-Acting Anesthetic Sales Value by Application
  9. 5.3.1 Global Short-Acting Anesthetic Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Short-Acting Anesthetic Sales Value by Application (2021-2032)
  11. 5.3.3 Global Short-Acting Anesthetic Sales Value Share by Application (2021-2032)
6 Short-Acting Anesthetic Regional Sales and Value Analysis
  1. 6.1 Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Short-Acting Anesthetic Sales by Region (2021-2032)
  3. 6.2.1 Global Short-Acting Anesthetic Sales by Region: 2021-2026
  4. 6.2.2 Global Short-Acting Anesthetic Sales by Region (2027-2032)
  5. 6.3 Global Short-Acting Anesthetic Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Short-Acting Anesthetic Sales Value by Region (2021-2032)
  7. 6.4.1 Global Short-Acting Anesthetic Sales Value by Region: 2021-2026
  8. 6.4.2 Global Short-Acting Anesthetic Sales Value by Region (2027-2032)
  9. 6.5 Global Short-Acting Anesthetic Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Short-Acting Anesthetic Sales Value (2021-2032)
  12. 6.6.2 North America Short-Acting Anesthetic Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Short-Acting Anesthetic Sales Value (2021-2032)
  15. 6.7.2 Europe Short-Acting Anesthetic Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Short-Acting Anesthetic Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Short-Acting Anesthetic Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Short-Acting Anesthetic Sales Value (2021-2032)
  21. 6.9.2 South America Short-Acting Anesthetic Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Short-Acting Anesthetic Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Short-Acting Anesthetic Sales Value Share by Country, 2025 VS 2032
7 Short-Acting Anesthetic Country-level Sales and Value Analysis
  1. 7.1 Global Short-Acting Anesthetic Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Short-Acting Anesthetic Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Short-Acting Anesthetic Sales by Country (2021-2032)
  4. 7.3.1 Global Short-Acting Anesthetic Sales by Country (2021-2026)
  5. 7.3.2 Global Short-Acting Anesthetic Sales by Country (2027-2032)
  6. 7.4 Global Short-Acting Anesthetic Sales Value by Country (2021-2032)
  7. 7.4.1 Global Short-Acting Anesthetic Sales Value by Country (2021-2026)
  8. 7.4.2 Global Short-Acting Anesthetic Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Short-Acting Anesthetic Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Short-Acting Anesthetic Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Short-Acting Anesthetic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Pharmacare
  2. 8.1.1 Aspen Pharmacare Company Information
  3. 8.1.2 Aspen Pharmacare Business Overview
  4. 8.1.3 Aspen Pharmacare Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Pharmacare Short-Acting Anesthetic Product Portfolio
  6. 8.1.5 Aspen Pharmacare Recent Developments
  7. 8.2 Baxter Healthcare
  8. 8.2.1 Baxter Healthcare Company Information
  9. 8.2.2 Baxter Healthcare Business Overview
  10. 8.2.3 Baxter Healthcare Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Healthcare Short-Acting Anesthetic Product Portfolio
  12. 8.2.5 Baxter Healthcare Recent Developments
  13. 8.3 Dr. Reddy's Laboratories
  14. 8.3.1 Dr. Reddy's Laboratories Company Information
  15. 8.3.2 Dr. Reddy's Laboratories Business Overview
  16. 8.3.3 Dr. Reddy's Laboratories Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio
  18. 8.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 8.4 Fresenius-Kabi
  20. 8.4.1 Fresenius-Kabi Company Information
  21. 8.4.2 Fresenius-Kabi Business Overview
  22. 8.4.3 Fresenius-Kabi Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius-Kabi Short-Acting Anesthetic Product Portfolio
  24. 8.4.5 Fresenius-Kabi Recent Developments
  25. 8.5 Hikma Pharmaceuticals
  26. 8.5.1 Hikma Pharmaceuticals Company Information
  27. 8.5.2 Hikma Pharmaceuticals Business Overview
  28. 8.5.3 Hikma Pharmaceuticals Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio
  30. 8.5.5 Hikma Pharmaceuticals Recent Developments
  31. 8.6 Hospira
  32. 8.6.1 Hospira Company Information
  33. 8.6.2 Hospira Business Overview
  34. 8.6.3 Hospira Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hospira Short-Acting Anesthetic Product Portfolio
  36. 8.6.5 Hospira Recent Developments
  37. 8.7 Paion
  38. 8.7.1 Paion Company Information
  39. 8.7.2 Paion Business Overview
  40. 8.7.3 Paion Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Paion Short-Acting Anesthetic Product Portfolio
  42. 8.7.5 Paion Recent Developments
  43. 8.8 Piramal Critical Care
  44. 8.8.1 Piramal Critical Care Company Information
  45. 8.8.2 Piramal Critical Care Business Overview
  46. 8.8.3 Piramal Critical Care Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Piramal Critical Care Short-Acting Anesthetic Product Portfolio
  48. 8.8.5 Piramal Critical Care Recent Developments
  49. 8.9 Septodont
  50. 8.9.1 Septodont Company Information
  51. 8.9.2 Septodont Business Overview
  52. 8.9.3 Septodont Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Septodont Short-Acting Anesthetic Product Portfolio
  54. 8.9.5 Septodont Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Short-Acting Anesthetic Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie Short-Acting Anesthetic Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 B. Braun
  68. 8.12.1 B. Braun Company Information
  69. 8.12.2 B. Braun Business Overview
  70. 8.12.3 B. Braun Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 B. Braun Short-Acting Anesthetic Product Portfolio
  72. 8.12.5 B. Braun Recent Developments
  73. 8.13 Cisen Pharmaceutical
  74. 8.13.1 Cisen Pharmaceutical Company Information
  75. 8.13.2 Cisen Pharmaceutical Business Overview
  76. 8.13.3 Cisen Pharmaceutical Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio
  78. 8.13.5 Cisen Pharmaceutical Recent Developments
  79. 8.14 Pfizer
  80. 8.14.1 Pfizer Company Information
  81. 8.14.2 Pfizer Business Overview
  82. 8.14.3 Pfizer Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Pfizer Short-Acting Anesthetic Product Portfolio
  84. 8.14.5 Pfizer Recent Developments
  85. 8.15 Yingke Biopharmaceutical
  86. 8.15.1 Yingke Biopharmaceutical Company Information
  87. 8.15.2 Yingke Biopharmaceutical Business Overview
  88. 8.15.3 Yingke Biopharmaceutical Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio
  90. 8.15.5 Yingke Biopharmaceutical Recent Developments
  91. 8.16 SSY Group
  92. 8.16.1 SSY Group Company Information
  93. 8.16.2 SSY Group Business Overview
  94. 8.16.3 SSY Group Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 SSY Group Short-Acting Anesthetic Product Portfolio
  96. 8.16.5 SSY Group Recent Developments
  97. 8.17 Baili-Pharm
  98. 8.17.1 Baili-Pharm Company Information
  99. 8.17.2 Baili-Pharm Business Overview
  100. 8.17.3 Baili-Pharm Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Baili-Pharm Short-Acting Anesthetic Product Portfolio
  102. 8.17.5 Baili-Pharm Recent Developments
  103. 8.18 Eisai
  104. 8.18.1 Eisai Company Information
  105. 8.18.2 Eisai Business Overview
  106. 8.18.3 Eisai Short-Acting Anesthetic Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Eisai Short-Acting Anesthetic Product Portfolio
  108. 8.18.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Short-Acting Anesthetic Value Chain Analysis
  2. 9.1.1 Short-Acting Anesthetic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Short-Acting Anesthetic Sales Mode & Process
  6. 9.2 Short-Acting Anesthetic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Short-Acting Anesthetic Distributors
  9. 9.2.3 Short-Acting Anesthetic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst